Articles & Video
Andreas Diacon, TASK Applied Science, announced as winner of Christine Pierre Lifetime Achievement Award 2019
At this year's Clinical Trials Europe, the Christine Pierre Lifetime Achievement Award 2019 was presented to Andreas Diacon, Founder, Director and & CEO at TASK Applied Science.
Life Sciences in 2020: Predictions from industry insiders
Industry insiders predict how life sciences will change in 2020 in emerging therapies, clinical trials, regulations and agriculture.
Clinical Trials Content Library: Whitepapers and Reports Collection
Explore our collection of exclusive whitepapers and reports covering the hottest topics in clinical trials with one simple registration.
Four things biotech and small pharma should know before selecting a CRO
This whitepaper offers a guide to biotechs and smaller pharma companies when looking to successfully partner with a CRO to outsource clinical trials.
How small pharma and biotechs can successfully partner with CROs
Michael Zörer, Head of Clinical Operations at AOP Orphan Pharmaceuticals, explores the unique challenges of building a successful partnership between big CROs and small pharma/biotechs.
The Top 10 Posts of 2019: Clinical Trials Innovation
We look back at 2019's most popular articles on innovating clinical trials in an interactive flip-book.
Pharma’s pivotal role in social determinants of health
Pharma manufacturers have a pivotal role to play in precision population health through strategic data collection, analysis, and biopsychosocial and algorithmic interventions to address SDOH.
Virtual trials and Real World Evidence: The global shift in clinical operations
We deep-dive into our State of the Industry Report 2019 to understand how companies are utilizing virtual trials and Real World Evidence in their clinical trial operations.
Clinical Trials Digital Week 2019 - 7 webinars on-demand
Register for Clinical Trials Digital Week 2019 for on-demand webinars and downloadable resources.
Leveraging Real World Evidence for drug approval
Since the introduction of the 21st Century Cures Act real world evidence has been gaining in popularity. We look at the opportunities and challenges it presents.
Real World Evidence: Revolutionizing the Clinical Trials Environment - WHITEPAPER
Download this exclusive whitepaper exploring how Real World Evidence is revolutionizing the clinical trials environment.
IoMT and Big Data : How the Internet of Medical Things impacts clinical trials
Explore how IoMT (the Internet of Medical Things) can benefit clinical trials through platforms and data management.
The impact of technological advances on clinical trials – INDUSTRY VOICES
Six clinical trials professionals look at the impact of technological advances on clinical trials.
How Virtual Trials and Real World Evidence are changing the CRO landscape
Dr. Raphaela Schnurbus, Clinical Solutions & Business Development Director at CRO OPIS, explores how Virtual Trials and Real World Evidence could change the clinical trials of the future.
Real-World-Evidence Mythbusting: 5 myths holding back patient-reported RWE adoption
What is holding back patient-reported Real-World-Evidence adoption in clinical trials? Bruce Hellman, CEO and Co-founder at uMotif, busts 5 myths.
How full virtual clinical trials can become reality in the next 10 years
How can virtual clinical trials be implemented in the next 10 years through EHRs, synthetic biology and nanopores? Michelle Petersen takes a deep dive.
Will in silico clinical trials revolutionize drug development?
Dr. Bertalan Meskó, The Medical Futurist, explores how in silico clinical trials and organs–on–chips could change drug development forever.
How patient-centricity can be achieved in clinical trials - INDUSTRY VOICES
We asked four clinical trial professionals to give their views regarding patient-centricity within the industry and the methods by which this can be achieved.
Taking an innovative approach to collecting real world evidence - Head of Clinical Development, BTG
INTERVIEW: Nermeen Varawalla, Head of Clinical Development at BTG, explores innovative approaches to generating real world evidence in clinical trials.
'Data is by definition creating trust and transparency in clinical trials' - Dr MaryAnne Rizk, Oracle
Dr MaryAnne Rizk, Global VP at Oracle, reveals how she sees data impacting clinical trials and the challenges that still need to be overcome in this exclusive interview.
How data transparency in clinical trials can transform patient recruitment and engagement
International calls for sharing the raw data in clinical trials have increased in recent years, yet it is still extremely difficult to obtain results.